基本信息
浏览量:0
职业迁徙
个人简介
Dr. Lei Zheng is an oncologist in Baltimore, caring for patients with conditions such as pancreatic cancer and gastrointestinal cancers. Regarded as one of the world’s top clinical specialists in pancreatic cancer, Dr. Zheng receives referrals from around the world.
He is an internationally recognized expert in the tumor microenvironment of pancreatic cancer and in mouse models of pancreatic cancer and preclinical studies of combinational immunotherapies. Dr. Zheng serves as co-director of the Pancreatic Cancer Precision Medicine Center of Excellence Program at the Johns Hopkins School of Medicine.
Dr. Zheng received his undergraduate degree in pre-medicine from Peking University in Beijing. He earned his M.D. at Peking Union Medical College and his Ph.D. in molecular medicine at the University of Texas Health Science Center. He completed his residency at Long Island Jewish Medical Center and performed a fellowship in medical oncology at Johns Hopkins.
He also completed a postdoctoral research fellowship in molecular medicine at the University of Texas Health Science Center and a postdoctoral research fellowship in biochemistry and molecular biology at Rockefeller University. Dr. Zheng joined the Johns Hopkins faculty in 2009.
Dr. Zheng is a NIH-funded researcher who currently holds two R01 grants as a PI, one P50 grant as project leader, seven R01 and one R21 grants as co-investigator and 11 industry-contracts for investigator-initiated preclinical and clinical combinational immunotherapy studies as PI. His research interests include pancreatic cancer biology and translational research; translational immunology and cancer immunotherapy; and the tumor microenvironment.
Dr. Zheng is director of the Multidisciplinary Hepato-Pancreato-Biliary Research Laboratory and the director of the NCI T32 Training Program on Surgical Oncology Research for the Department of Surgery. He holds numerous leadership roles, including chair of the China Advisory Group for the International Affairs Committee of the American Association for Cancer Research and editor-in-chief of the Annals of Pancreatic Cancer. He was recognized at the 45th Anniversary Meeting of the American Pancreas Association with the 2014 Hirshberg Award in Pancreatic Cancer. He has published extensively, including multiple book chapters, and was an editor of the book, Pancreatic Cancer.
Dr. Zheng is a member of several professional organizations, including the Chinese American Hematologist Oncologist Network (CAHON), the International Hepato-Pancreato-Biliary Association (IHPBA) and the American Pancreas Association (APA).
He is an internationally recognized expert in the tumor microenvironment of pancreatic cancer and in mouse models of pancreatic cancer and preclinical studies of combinational immunotherapies. Dr. Zheng serves as co-director of the Pancreatic Cancer Precision Medicine Center of Excellence Program at the Johns Hopkins School of Medicine.
Dr. Zheng received his undergraduate degree in pre-medicine from Peking University in Beijing. He earned his M.D. at Peking Union Medical College and his Ph.D. in molecular medicine at the University of Texas Health Science Center. He completed his residency at Long Island Jewish Medical Center and performed a fellowship in medical oncology at Johns Hopkins.
He also completed a postdoctoral research fellowship in molecular medicine at the University of Texas Health Science Center and a postdoctoral research fellowship in biochemistry and molecular biology at Rockefeller University. Dr. Zheng joined the Johns Hopkins faculty in 2009.
Dr. Zheng is a NIH-funded researcher who currently holds two R01 grants as a PI, one P50 grant as project leader, seven R01 and one R21 grants as co-investigator and 11 industry-contracts for investigator-initiated preclinical and clinical combinational immunotherapy studies as PI. His research interests include pancreatic cancer biology and translational research; translational immunology and cancer immunotherapy; and the tumor microenvironment.
Dr. Zheng is director of the Multidisciplinary Hepato-Pancreato-Biliary Research Laboratory and the director of the NCI T32 Training Program on Surgical Oncology Research for the Department of Surgery. He holds numerous leadership roles, including chair of the China Advisory Group for the International Affairs Committee of the American Association for Cancer Research and editor-in-chief of the Annals of Pancreatic Cancer. He was recognized at the 45th Anniversary Meeting of the American Pancreas Association with the 2014 Hirshberg Award in Pancreatic Cancer. He has published extensively, including multiple book chapters, and was an editor of the book, Pancreatic Cancer.
Dr. Zheng is a member of several professional organizations, including the Chinese American Hematologist Oncologist Network (CAHON), the International Hepato-Pancreato-Biliary Association (IHPBA) and the American Pancreas Association (APA).
研究兴趣
论文共 63 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 7_Supplement (2023): 3241-3241
Yining Zhu, Jingyao Ma, Ruochen Shen,Jinghan Lin, Shuyi Li,Xiaoya Lu,Jessica L. Stelzel,Jiayuan Kong,Leonardo Cheng,Ivan Vuong,Zhi-Cheng Yao, Christine Wei,
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
Cancer Researchno. 7_Supplement (2023): 2768-2768
Lei Zheng, Rong Wang, Jie Lin,Xuefei Yan,Xiaoxi Xu,Xinhe Feng,Annie An,Jessie Wang,Kaixia Lian,Ludovic Bourre,Xiaolong Tu, Demi X Liu,
Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)
European Journal of Nuclear Medicine and Molecular Imagingno. 13 (2022): 4369-4381
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn